EPS Bio Technology Corp. (TPEX:4183)

EPS Bio Technology Revenue

EPS Bio Technology had revenue of 63.38M TWD in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 443.44M, down -6.22% year-over-year. In the year 2025, EPS Bio Technology had annual revenue of 499.70M with 10.78% growth.

• Revenue (ttm): 443.44M
• Revenue Growth: -6.22%
• P/S Ratio: 0.75
• Revenue / Employee: 4.11M
• Employees: 108
• Market Cap: 333.20M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	499.70M	48.62M	10.78%
Dec 31, 2024	451.08M	-19.08M	-4.06%
Dec 31, 2023	470.17M	6.72M	1.45%
Dec 31, 2022	463.45M	-16.83M	-3.50%
Dec 31, 2021	480.28M	2.68M	0.56%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 19, 2026

Data Sources Report a data error